Related content

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

By Kono Toru   Hata Taishi   Morita Satoshi   Munemoto Yoshinori   Matsui Takanori   Kojima Hiroshi   Takemoto Hiroyoshi   Fukunaga Mutsumi   Nagata Naoki   Shimada Mitsuo   Sakamoto Junichi   Mishima Hideyuki  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1283-1290

Springer Publishing Company

Access to resources Recommend Favorite

Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial

By Hu Zhihuang   Cheng Ying   Zhang Hongyu   Zhou Caicun   Han Baohui   Zhang Yiping   Huang Cheng   Chang Jianhua   Song Xiangqun   Liang Jun   Liang Houjie   Bai Chunxue   Yu Shiying   Chen Jia   Wang Jie   Pan Hongming   Chitkara Denesh   Hille Darcy   Zhang Li  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite

Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer

By Awidi A.   Homsi U.   Kakail R.I.   Mubarak A.   Hassan A.   Kelta M.   Martinez P.   Sulaiti S.   Al Qady A.   Jamhoury A.   Daniel M.   Charles C.   Ambrose A.   El-Aloosy A.S.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2010-2014

Elsevier

Access to resources Recommend Favorite

Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial

By Rastelli Antonella   Taylor Marie   Gao Feng   Armamento-Villareal Reina   Jamalabadi-Majidi Shohreh   Napoli Nicola   Ellis Matthew  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 107-116

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

By Saito H.   Yoshizawa H.   Yoshimori K.   Katakami N.   Katsumata N.   Kawahara M.   Eguchi K.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1067-1073

Oxford University Press

Access to resources Recommend Favorite